Hmmmm ..... I guess I may have been undervaluing/overlooking Hepalink's potential partnership role with RVX? I viewed them as an Investor and potential Asian sales/distribution partner. But with Ori entering the picture, i'm wondering if Ori's relationship with Hepalink could potentially offer a scenario whereby RVX & Hepalink link up at a deeper level? ... manufacturing, sales, distribution, the whole "shebang"? ... with Ori leadership, influence, connections, and funding gluing it all together? 

As investors, they/we all (Ori, Hepalink, RVX, us) would STILL win BIG in the event of a BP transaction ... but having a viable standalone model in place works well for organizing for Naz & investor optics, helpful leverage for negotiating with BP's, and just also the potential of operating successfully without a BP partner (as a possibility?) if necessay, and for extended leverage.

Geez just so many things to think about in a situation like RVX lol ... thankfully, so many things will be a little clearer in less than 2 days ...

... btw, where is the countdown clock to 8:30 am Monday morning?! :)